Esophageal varices. I. Clinical presentation, medical therapy, and endoscopic therapy

Gastroenterology Clinics of North America

Volumn 29, Issue 2, 2000, Pages 337-385

  Luketic, Velimir A ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; GLYCERYL TRINITRATE; SOMATOSTATIN; VASOPRESSIN;

DISEASE CLASSIFICATION; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES; HUMAN; PORTAL HYPERTENSION; REVIEW; TREATMENT INDICATION;

EID: 0034030213     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70119-9     Document Type: Article

References (326)

1. S.K. Acharya S. Dasarathy S. Saksena A prospective randomized study to evaluate propanolol in patients undergoing long-term sclerotherapy J Hepatol 19 1993 291
2. E. Akriviadis J. Korula S. Gupta Frequent endoscopic variceal sclerotherapy increases risk of complications: Prospective randomized controlled study of two treatment schedules Dig Dis Sci 34 1989 1068
3. A. Albillos L. Colombato F.Y. Lee Octreotide ameliorates vasodilation and Na retention in portal hypertensive rats Gastroenterology 104 1993 575
4. P. Alexandrino M.M. Alves P. Fidalgo Is sclerotherapy the first-choice treatment of oesophageal variceal bleeding in cirrhotic patients? Final report of a randomized clinical trial J Hepatology 11 suppl 1990 S1
5. P.T. Alexandrino M.M. Alves J. Pinto Correia Propanolol or endoscopic sclerotherapy in the prevention of recurrence of variceal hemorrhage J Hepatol 7 1988 175
6. American Society for Gastrointestinal Endoscopy Technology Assessment Status Evaluation—update: Endoscopic band ligation. November, 1996. ASGE Gastrointest Endosc 47 1998 573
7. T. Andreani R.E. Poupon G.B.J. Balkau Efficacite comparee du propranolol et de sclerose endoscopique de varices oesophagienned dans la prevention des recidives d'hemorragies digestives au cours des cirrhosis. Etude controlee Gastroenterol Clin Biol 15 suppl 1991 A215
8. T. Andreani R.E. Poupon G.B.J. Balkau Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propanolol, endoscopic sclerotherapy and placebo Hepatology 12 1990 1413
9. M. Angelico L. Carli C. Piat Effects of isisorbide 5 mononitrate compared to propanolol on first bleeding and long-term survival in cirrhosis Gastroenterology 113 1997 1632
10. M. Angelico L. Carli C. Piat Isosorbide-5-mononitrate versus propanolol in the prevention of the first bleeding in cirrhosis Gastroenterology 104 1993 1460
11. T. Aramaki T. Sekiyama Y. Katsuta Long-term hemodynamic effects of a 4 week regimen of nipradilol, a new β blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis, a comparative study with propanolol J Hepatol 15 1992 48
12. A. Avgerinos A. Armonis Balloon tamponade technique and efficacy in variceal haemorrhage Scand J Gastroenterol 207 1994 11
13. A. Avgerinos A. Armonis S. Raptis Somatostatin and octreotide in the management of acute variceal hemorrhage Hepatogastroenterology 42 1995 145
14. A. Avgerinos C. Klonis G. Rekoumis A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage J Hepatol 13 1991 78
15. A. Avgerinos G. Rekoumis C. Klonis Propanolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy J Hepatol 19 1993 301
16. M.S. Barsoum F.I. Bolous A. El-Rooby Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices Br J Surg 69 1982 76
17. S. Battista F. Bar G. Mengozzi Hyperdynamic circulation in patients with cirrhosis: Direct measurement of nitric oxide levels in hepatic and portal veins J Hepatol 26 1997 75
18. J.N. Baxter S.A. Jenkins Somatostatin: An alternative to sclerotherapy? Scand J Gastroenterol 207 suppl 1994 17
19. F. Bendtsen J.H. Henriksen U. Becker Long-term effects of oral propanolol on splanchnic and systemic hemodynamics in patients with cirrhosis and oesophageal varices Scand J Gastroenterol 26 1991 933
20. F. Bendtsen J.H. Henriksen T.I.A. Sorensen Propanolol and hemodynamic responses in cirrhosis J Hepatol 13 1991 144
21. F. Bendtsen L. Simonsen J.H. Henriksen Effect on hemodynamics of a liquid meal alone and in combination with propanolol in cirrhosis Gastroenterology 102 1992 1017
22. J.N. Benoit D.N. Granger Splanchnic hemodynamics in chronic portal hypertension Semin Liver Dis 6 1986 287
23. J.N. Benoit D.N. Granger Intestinal microvascular alterations associated with chronic portal hypertension Fed Proc 45 1986 417
24. K. Beppu K. Inokuchi N. Koyanagi Prediction of variceal hemorrhage by esophageal endoscopy Gastrointest Endosc 27 1981 213
25. G. Bertoni G. Fornaciari M. Beltrami Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: A randomized pilot study J Clin Gastroenterol 12 1990 364
26. I. Besson P. Ingrand B. Person Sclerotherapy with or without octreotide for acute variceal bleeding N Engl J Med 333 1995 555
27. D.K. Bhargava R. Pokharna Endoscopic variceal ligation versus endoscopic variceal ligation and endoscopic sclerotherapy: A prospective randomized study (see comments) Am J Gastroenterol 92 1997 950
28. P.S. Bhathal R.J. Groszmann Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators J Hepatol 1 1985 325
29. L. Blanchet D. LeBREC Changes in splanchnic blood flow in portal hypertensive rats Eur J Clin Invest 12 1982 327
30. A.T. Blei J. Gottstein Isosorbide dinitrate in experimental portal hypertension: A study of factors that modulate the hemodynamic response Hepatology 16 1986 107
31. A.T. Blei R.J. Groszmann A.P. Shepherd The Physiology of the Intestinal Microcirculation 1984 Raven Press New York 377
32. S.R. Bloom J.M. Polak Somatostatin BMJ 295 1987 288
33. L. Bolondi A. Gatta R.J. Groszmann Session IV, Baveno II Consensus statements: Imaging techniques and haemodynamic measurements in portal hypertension R. De Franchis Portal Hypertension II Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies 1996 Blackwell Science Oxford
34. A. Bomzon L. Blendis The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis Hepatology 20 1994 1343
35. J. Bosch J.M. Bordas J. Rigau Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: Comparison with measurements with variceal puncture in patients undergoing endoscopic sclerotherapy Hepatology 6 1986 667
36. J. Bosch R.J. Groszmann J.C. Garcia-Pagan Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: A placebo-controlled clinical trial Hepatology 10 1989 962
37. J. Bosch D. Kravetz J. Rodes Effects of somatostatin on hepatic hemodynamics in patients with cirrhosis of the liver and in normal subjects Gastroenterology 80 1981 518
38. J. Bosch R. Masti D. Kravetz Effects of propranolol on azygous venous blood flow and hepatic and systemic hemodynamics in cirrhosis Hepatology 4 1984 1200
39. C. Boustiere O. Dumas C. Jouffre Endoscopic ultrasonography classification of gastric varices in patients with cirrhosis: Comparison of endoscopic findings J Hepatol 19 1993 268
40. A. Braillon P. Cales D. Lebrec Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic hemodynamics in patients with cirrhosis Int J Clin Pharm Res 5 1985 223
41. A. Braillon P. Cales D. Valla Influence of the degree of liver failure on systemic and splanchnic hemodynamics and on response to propranolol in patients with cirrhosis Gut 27 1986 1204
42. A. Braillon M.I. Jiron D. Valla Effect of propranolol on hepatic blood flow in patients with cirrhosis Clin Pharm Ther 37 1985 376
43. A. Braillon R. Moreau A. Hadenegue Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension: Effect of propranolol J Hepatol 9 1989 312
44. P. Brazeau W. Vale R. Burgus Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone Science 179 1973 77
45. A.K. Burroughs Octreotide in variceal bleeding Gut 35 1994 S23
46. A.K. Burroughs N.M. Bass D. Osborne Randomized, controlled study of transhepatic obliteration of varices and oesophageal stapling transection in uncontrolled variceal haemorrhage Liver 3 1983 122
47. A.K. Burroughs G. Hamilton A. Phillips A comparison of sclerotherapy with staple transection of the oesophagus for the emergency control of bleeding from esophageal varices N Engl J Med 321 1989 857
48. A.K. Burroughs W.J. Jenkins S. Sherlock Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis N Engl J Med 309 1983 1539
49. A.K. Burroughs P.A. McCormick Prevention of variceal rebleeding Gastroenterol Clin North Am 21 1992 119
50. A.K. Burroughs P.A. McCormick M.D. Hughes Randomized, double-blind placebo-controlled trial of somatostatin for variceal bleeding Gastroenterology 99 1990 1388
51. A.K. Burroughs P.A. McCormick S. Siringo Randomized trial of long-term sclerotherapy for variceal rebleeding using the same protocol to treat rebleeding in all patients: A final report [abstr] Gut 30 1989 A1506
52. A.K. Burroughs E. Panagou Pharmacological therapy for portal hypertension: Rationale and results Semin Gastrointest Dis 6 1995 148
53. H. Butler The veins of the esophagus Thorax 6 1951 276
54. P. Cales the Study Group of Primary Prophylaxis Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients Gastroenterol Clin Biol 16 1992 504
55. P. Cales A. Braillon M.I. Jiron Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis: Lack of correlation with oesophageal varices and gastrointestinal bleeding: Effect of propranolol J Hepatol 1 1984 37
56. P. Cales H. Desmorat A. Ravaud Incidence and rate of occurrence of large oesophageal varices in cirrhotic patients: Application to screening for prophylaxis of first haemorrhage J Hepatol 7 1988 S15
57. P. Cales H. Desmorat J.P. Vinel Incidence of large oesophageal varices in patients with cirrhosis: Application to prophylaxis of first variceal bleeding Gut 31 1990 1298
58. G.C. Caletti E. Brocchi A. Ferrari Value of endoscopic ultrasonography in the management of portal hypertension. Endoscopy 24 suppl 1 1992 342
59. B. Campillo P.N. Bories C. Benvenuti Serum and urinary nitrate levels in liver cirrhosis: Endotoxemia, renal function and hyperdynamic circulation J Hepatol 25 1996 707
60. B. Caujolle F. Ballet R. Poupon Relationship among beta-adrenergic blockade, propranolol concentration and liver function in patients with cirrhosis Scand J Gastroenterol 23 1988 925
61. J.H. Cello R. Crass D.D. Trunkey Endoscopic sclerotherapy versus esophageal transection in Child's class C patients with variceal hemorrhage Surgery 91 1982 333
62. J.H. Cello J.H. Grendell R.A. Crass Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage N Engl J Med 316 1987 11
63. P. Cerbelaud A. Lavignolle D. Perrin Propranolol et prevention des recidives des ruptures de varice oesophagienne du cirrhotique Gastroenterol Clin Biol 10 1986 18A
64. J. Cervinka V. Kordac M. Kalab Effect of per oral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver J Int Med Res 17 1988 560
65. E. Christensen L. Faverholdt P. Schilchling Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisolone Gastroenterology 81 1981 520
66. G. Cioni P. D'Alimonte F. Zerbinati Duplex-Doppler ultrasonography in the evaluation of cirrhotic patients with portal hypertension and in the analysis of their response to drugs J Gastroenterol Hepatol 7 1992 388
67. J. Colman P. Jones C. Finch Propranolol in the prevention of variceal hemorrhage in alcoholic cirrhotic patients Hepatology 12 1990 851
68. L.A. Colombato A. Albillos R.J. Groszmann Temporal relationship of peripheral vasodilation, plasma volume expansion and the hyperdynamic circulatory state in portal hypertensive rats Hepatology 15 1991 323
69. M. Colombo R. deFranchis M. Tommasini Beta blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial Hepatology 9 1989 433
70. H.O. Conn N.D. Grace J. Bosch Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial Hepatology 13 1991 902
71. F. Consolo S. Pustorino [Theoretical and physiopharmacological bases of the somatostatin treatment in digestive diseases] Minerva Chir 47 1992 723
72. Meta-analysis as a tool for interpreting clinical trials in liver disease: Proceedings of a workshop in Erice, Italy. 1990
73. A.E. Dagradi The natural history of esophageal varices in patients with alcoholic liver disease: An endoscopic and clinical study Am J Gastroenterol 57 1972 520
74. G. D'Amico L. Pagliaro J. Bosch The treatment of portal hypertension: A meta-analytic review Hepatology 22 1995 332
75. S. Dasarathy M. Dwidi D.K. Bhargava A prospective randomized trial comparing repeated endoscopic sclerotherapy to propranolol in decompensated (Child B and C) cirrhotic patients Hepatology 16 1992 89
76. B.K. De U.C. Ghoshal T. Das Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: Preliminary report of a randomized controlled trial J Gastroenterol Hepatol 14 1999 220
77. F.T. DeDombal J.R. Clarke S.E. Clamp Prognostic factors in upper G.I. bleeding Endoscopy 18 1986 6s
78. J. Deflandre V. Gillard J. Pirotte Effect du sotaolol sur la pression sus-hepatique bloquee de malades cirrhotiques Ann Gastroenterol Hepatol 23 1988 359
79. R. DeFranchis Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices N Engl J Med 319 1988 983
80. R. DeFranchis Treatment of bleeding oesophageal varices: A meta-analysis Scand J Gastroenterol 207 suppl 1994 29
81. R. DeFranchis J.P. Pascal E. Ancona Definitions, methodology and therapeutic strategies in portal hypertension: A consensus development workshop J Hepatol 15 1992 256
82. R. DeFranchis M. Primignani Why do varices bleed? Gastroenterol Clin North Am 21 1992 85
83. J. de la Pena M. Rivero E. Sanchez Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: Prospective randomized trial Gastrointest Endosc 49 1999 417
84. B. Dennert F.C. Ramirez R.A. Sanowski A prospective evaluation of the endoscopic spectrum of overtube-related esophageal mucosal injury Gastrointest Endosc 45 1997 134
85. J.M. Dollet B. Champignuelle A. Patris Sclerotherapy endoscopique contre propranolol apres hemoragie par rupture de varices oesophagiennes chez le cirrhotique: resultants a 4 ans d'une etude randomisee Gastroenterol Clin Biol 12 1988 234
86. D.E. Drayer Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers Pharmacotherapy 7 1987 87
87. M.C. Dufour J.E. Everhart Chronic liver disease and cirrhosis. In : Digestive Diseases in the United States: Epidemiology and Impact 1994 National Institutes of Health, U.S. Government Printing Office Washington, DC 613 646
88. A. El-Zayadi S. El-Din M. Kabil Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease Gastrointest Endosc 34 1988 314
89. M. Epstein J.R. Oster Beta-blockers and the kidney Miner Electrolyte Metab 8 1982 237
90. L.S. Eriksson D.H. Law J. Wahren Influence of somatostatin on splanchnic hemodynamics in patients with cirrhosis Clin Physiol 4 1984 616
91. A. Escorsell J.C. Bandi E. Francois Desensitation of the effects of intravenous octreotide in cirrhotic patients with portal hypertension [abstr] Hepatology 24 1996 207A
92. A. Escorsell J.M. Bordas L.R. del Arbol Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group J Hepatol 29 1998 779
93. L. Ferayorni J. Polio R.J. Groszmann Drug therapy for portal hypertension: A 5 year review R. DeFranchis Portal Hypertension II: Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies 1996 Blackwell Science Oxford 68 97
94. W.E. Fleig E.F. Stange E. Hunecke Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: Prospective randomized comparison of propranolol and sclerotherapy Hepatology 7 1987 355
95. E. Fort D. Sautereau C. Silvain A randomized trial of terlipressin plus nitroglycerin vs balloon tamponade in the control of acute variceal hemorrhage Hepatology 11 1990 678
96. J.G. Freeman J.R. Barton C.O. Record Effect of isosorbide dinitrate, verapamil and labetalol on portal pressure in cirrhosis BMJ 291 1985 561
97. J.G. Freeman M.D. Cobden C.O. Record Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal hemorrhage J Clin Gastroenterol 11 1989 58
98. W.H. Frishman Nadolol: A new beta-adrenoceptor antagonist N Engl J Med 305 1982 678
99. S. Gaiani L. Bolondi D. Fenyves Effect of propranolol on portasystemic collateral circulation in patients with cirrhosis Hepatology 14 1991 824
100. J.C. Garcia-Pagan J. Bosch J. Rodes The role of vasoactive mediators in portal hypertension Semin Gastrointest Dis 6 1995 140
101. J.C. Garcia-Pagan F. Feu J. Bosch Propranolol compared with propranolol plus isosorbide 5-mononitrate for portal hypertension in cirrhosis: A randomized controlled study Ann Intern Med 114 1991 869
102. J. Garcia-Pagan F. Feu M. Nevasa Long-term hemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension J Hepatol 11 1990 189
103. G. Garcia-Tsao N.D. Grace R.J. Groszmann Short-term effects of propranolol on portal hypertension Hepatology 6 1986 101
104. G. Garcia-Tsao R.J. Groszman Portal hemodynamics during nitroglycerin administration in cirrhotic subjects Hepatology 7 1987 805
105. G. Garcia-Tsao R. Groszmann R.L. Fisher Portal pressures, presence of gastroesophageal varices and variceal bleeding Hepatology 5 1985 419
106. O.J. Garden P.R. Mills G.G. Birnie Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients Gastroenterology 98 1990 185
107. A. Gatta C. Merkel D. Sacerdoti Nadolol for prevention of variceal rebleeding in cirrhosis: A controlled clinical trial Digestion 37 1987 22
108. G.E. Gerunda D. Neri F. Zangrandi Nadolol does not reduce early rebleeding in cirrhotics undergoing endoscopic variceal sclerotherapy: A multicenter randomized controlled trial Hepatology 12 1990 988
109. P.R. Gibson A.J. McClean F.J. Dudley The hypotensive effect of oral nitroglycerin on portal venous pressure in patients with cirrhotic portal hypertension J Gastroenterol Hepatol 1 1986 201
110. A.E. Gimson J.K. Ramage M.Z. Panos Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices (see comments) Lancet 342 1993 391
111. A.E.S. Gimson D. Westaby J. Hegarty A randomized controlled trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage Hepatology 6 1986 410
112. P. Gines J. Salmeron V. Arroyo Effects of somatostatin on renal function in cirrhosis Gastroenterology 103 1992 1868
113. G.J. Gores R.W. Wilsner E.R. Dickson Prospective evaluation of esophageal varices in primary biliary cirrhosis: Development, natural history and influence on survival Gastroenterology 96 1989 1552
114. C.J. Gostout Endoscopic esophageal variceal band ligation: How intensively should we ligate? [edit; comment] Am J Gastroenterol 93 1998 135
115. P.C. Gotzsche I. Gjorup H. Bonnen Somatostatin v placebo in bleeding oesophageal varices: Randomised trial and meta-analysis BMJ 310 1995 1495
116. N.D. Grace A hepatologists view of variceal bleeding Am J Surg 160 1990 26
117. N.D. Grace Prevention of initial variceal hemorrhage Gastroenterol Clin North Am 21 1992 149
118. N.D. Grace Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee Am J Gastroenterol 92 1997 1081
119. N.D. Grace H.O. Conn R.J. Groszmann Propranolol for prevention of first variceal hemorrhage (EVH): A lifetime commitment Hepatology 12 1990 407
120. N.D. Grace H.O. Conn R.H. Resnick Distal splenorenal vs portal-systemic shunts after hemorrhage from varices: A randomized controlled trial Hepatology 8 1988 1475
121. D.Y. Graham J.L. Smith The course of patients after variceal hemorrhage Gastroenterology 80 1981 800
122. Gregory PB, and the VA Cooperative Variceal Sclerotherapy Group: Sclerotherapy for male alcoholics with cirrhosis who have bled from esophageal varices: A randomized controlled trial [abstr]. World Congress of Gastroenterology Proceedings, Sidney, 1990
123. R.J. Groszmann J. Bosch N.D. Grace Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage Gastroenterology 99 1990 1401
124. T.K. Gupta L. Chen R.J. Groszmann Pathophysiology of portal hypertension Clin Liver Dis 1 1997 1
125. T.K. Gupta R.J. Groszmann Administration of l -arginine: The physiological precursor of NO reduces portal perfusion pressure and ameliorates hepatic hyperreactivity in experimental cirrhosis Hepatology 20 1994 200
126. E. Hanisch J. Doertenbach K.H. Usadel Somatostatin in acute bleeding oesophageal varices: Pharmacology and rationale for use Drugs 44 suppl 2 1992 24
127. M. Hartleb P.P. Michielsen A. Dziurkowska Marek The role of nitric oxide in portal hypertensive systemic and portal vascular pathology Acta Gastroenterol Belg 60 1997 222
128. P.C. Hayes S. Crichton A.N. Shepherd Propranolol in chronic liver disease: A controlled trial of its effect and safety over twelve months QJM 246 1987 823
129. P.C. Hayes J.M. Davis J.A. Lewis Meta-analysis of value of propranolol in prevention of variceal hemorrhage Lancet 336 1990 153
130. P.C. Hayes D. Westaby R. Williams Effect and mechanism of action of isosorbide 5-mononitrate Gut 29 1988 752
131. R.K. Heaton I. Grant C.G. Matthews Comprehensive norms for an expanded Halstead-Reitan battery: Demographic corrections, research findings and clinical applications 1991 Psychological Assessments Resources Odessa
132. P. Hillon L. Blanchet D. Lebrec Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats Clin Sci 63 1982 29
133. B.B. Hoffman R.J. Lefkowitz Adrenergic receptor antagonists A. Goodman-Gilman The Pharmacological Basis of Therapeutics ed 8 1990 Pergamon Press New York 221 243
134. M.C. Hou H.C. Lin F.Y. Chang Oesophageal perforation following endoscopic variceal ligation and balloon tamponade J Gastroenterol Hepatol 9 1994 659
135. M.C. Hou H.C. Lin B.I. Kuo Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial Hepatology 21 1995 1517
136. C.N. Housset D.C. Rockey S.L. Friedman Hepatic lipocytes: A major target for endothelin-1 J Hepatol 22 1995 55
137. W. Huizinga I. Angorn L. Baker Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk Surg Gynecol Obstet 160 1985 539
138. S.J. Hwang H.C. Lin C.F. Chang A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding J Hepatol 16 1992 320
139. G. Ideo G. Bellati E. Fesce Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: A prospective randomized study Hepatology 8 1988 6
140. International Octroetide Varices Study Group Double blind RCT of 5 day octreotide versus placebo associated with sclerotherapy for trial/failures [abstr] Hepatology 24 1996 352A
141. T. Iwao A. Toyonaga M. Sumino Effect of intraportal nitroglycerin on portosystemic hemodynamics in patients with cirrhosis: Comparison with i.v.route J Clin Gastroenterol 13 1991 424
142. T. Iwao A. Toyonaga M. Sumino Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis Hepatology 13 1991 124
143. F. Iwata T. Joh T. Kawai Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats Am J Physiol 163 1992 G149
144. J.L. Jaramillo M. de la Mata G. Mino Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices: A randomized pilot study J Hepatol 12 1991 100
145. S.A. Jenkins J.N. Baxter W. Corbett A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal hemorrhage BMJ 290 1985 275
146. S.A. Jenkins J.N. Baxter W.A. Corbett Effects of a somatostatin analogue SMS 201–995 on hepatic hemodynamics in the pig and on intravariceal pressure in man Br J Surg 72 1985 1009
147. S.A. Jenkins J.N. Baxter S. Snowden The effect of somatostatin and SMS-201–995 on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension Fibrinolysis 2 1988 48
148. S.A. Jenkins R. Shields M. Davies A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage Gut 41 1997 526
149. D.M. Jensen T.O. Kovacs G.M. Randall Initial results of a randomized study of emergency banding vs sclerotherapy for bleeding gastric or esophageal varices Gastrointest Endosc 39 1993 279
150. L.S. Jensen N. Krarup Propranolol may prevent recurrence of esophageal varices after obliteration by endoscopic sclerotherapy Scand J Gastroenterol 25 1990 352
151. M.I. Jiron B. Delhotal D. Lebrec Relationship between dose, blood level and hemodynamic response in patients with cirrhosis receiving propranolol Eur J Clin Pharmacol 28 1985 353
152. P.A. Johnson D.R. Campbell C.W. Antonson Complications associated with endoscopic band ligation of esophageal varices (see comments) Gastrointest Endosc 39 1993 181
153. S.J. Johnson J.E. Hines A.E. Burt Phenotypic modulation of perisinusoidal cells following acute liver injury: A quantitative analysis Int J Exp Pathol 73 1992 765
154. D. Kahn B. Jones P.C. Bornman Incidence and management of complications after injection sclerotherapy: A ten-year prospective evaluation Surgery 105 1989 160
155. H. Kanazawa S. Matsusaka N. Tada Measurement of azygos blood flow by a continuous thermodilution method in liver disease Acta Hepatol Jpn 27 1986 1132
156. N. Kawada T.A. Tran-Thi H. Klein The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances: Possible involvement of endothelin-1 and NO in the regulation of the sinusoidal tonus Eur J Biochem 213 1993 815
157. C.F. Kiire Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis BMJ 298 1989 1363
158. T. Kim H. Shijo H. Tokumitsu Risk factors for hemorrhage from gastric fundal varices Hepatology 25 1997 307
159. S. Kitano N. Koyanagi Y. Iso Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate Hepatology 7 1987 810
160. C.W. Kong C.S. Lay Y.T. Tsai Hemodynamic effect of propranolol on portal hypertension in patients with HBsAG-positive cirrhosis Dig Dis Sci 31 1986 1303
161. J. Korula L.A. Balart G. Radvan A prospective randomized controlled trial of chronic esophageal variceal sclerotherapy Hepatology 5 1985 584
162. A. Koshy C. Girod S.S. Lee Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats Hepatology 9 1989 269
163. D. Kravetz J. Bosch M. Arderui Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: Influence of the extent of portal-systemic shunting Hepatology 9 1989 808
164. D. Kravetz J. Bosch J. Teres Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage Hepatology 4 1984 442
165. D. Kravetz S.A. Cummings R.J. Groszmann Hyposensitivity to vasopressin in a haemorrhaged-transfused rat model of portal hypertension Gastroenterology 93 1987 170
166. D. Kravetz E. Sikuler R.J. Groszmann Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution Gastroenterology 90 1986 1232
167. R.J. Kroeger R.J. Groszmann Increased portal venous resistance hinders portal pressure reduction during the administration of β-adrenergic blocking agents in a portal hypertensive model Hepatology 5 1985 97
168. J.M. LaBerge E.J. Ring R.L. Gordon Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: Results in 100 patients Radiology 187 1993 413
169. L. Laine D.J. Cook Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding Ann Intern Med 123 1995 280
170. L. Laine H.M. El-Newihy B. Migikovsky Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices Ann Intern Med 119 1993 1
171. L. Laine C. Stein V. Sharma Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices (see comments) Gastroenterology 110 1996 529
172. A.W. Larson H. Cohen B. Zweiban Acute esophageal variceal sclerotherapy: Results of a prospective randomized trial JAMA 255 1986 497
173. C.S. Lay Y.T. Tsai C.Y. Teg Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices Hepatology 25 1997 1347
174. D. Lebrec Pharmacologic treatment of portal hypertension: Hemodynamic effects and prevention of bleeding Pharmacol Ther 61 1994 65
175. D. Lebrec P. Hillon C. Munoz The effect of propranolol on portal hypertension in patients with cirrhosis: A hemodynamic study Hepatology 2 1982 523
176. D. Lebrec T. Poynard J. Bernuau A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A final report Hepatology 4 1984 355
177. D. Lebrec T. Poynard J.P. Capron Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis, a randomized trial J Hepatol 7 1988 118
178. V.K. Leung J.J. Sung A.T. Ahuja Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding Gastroenterology 112 1997 1811
179. H.C. Lin O. Soubrane S. Cailmail Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats J Hepatol 13 1991 213
180. G.H. Lo K.H. Lai C.F. Chang Endoscopic injection sclerotherapy vs. endoscopic variceal ligation in arresting acute variceal bleeding for patients with advanced hepatocellular carcinoma J Hepatol 21 1994 1048
181. G.H. Lo K.H. Lai J.S. Cheng Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: A prospective, randomized trial J Hepatol 31 1999 451
182. G.H. Lo K.H. Lai J.S. Cheng Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices Hepatology 25 1997 1101
183. M.S. Losowsky D.P. Jones C.S. Lieber Local factors in ascites formation during sodium retention in cirrhosis N Engl J Med 275 1966 750
184. L. Lundell R. Leth T. Lind Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions Acta Chir Scand 156 1990 711
185. U.A. Marbet A. Straumann K.E. Gyr Reduction in early recurrence of variceal bleeding by propranolol Scand J Gastroenterol 23 1988 369
186. P. Marteau F. Ballet Y. Chretien Effect of vasodilators on hepatic microcirculation: A study of the inhibition of norepinephrine-induced vasoconstriction in the isolated perfused rat liver Hepatology 8 1988 228
187. T. Martin A. Taupignon Z.A. Lavignolle Prevention des recifives hemorragiques chez des malades atteints de cirrhose: Resultants d'une etude controlee comparant propranolol et sclerose endoscopique Gastroenterol Clin Biol 15 1991 833
188. R. Mastai J. Bosch J. Bruix β-Blockade with propranolol and hepatic artery blood flow in patients with cirrhosis Hepatology 10 1989 269
189. R. Mastai J. Bosch M. Navasa Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on zygos blood flow in patients with cirrhosis and portal hypertension J Hepatol 4 1987 71
190. P.A. McCormick A.K. Burroughs N. McIntyre How to insert a Sengstaken-Blakemore tube Br J Hosp Med 43 1990 274
191. P.A. McCormick F. Feu C. Sabrin Propranolol and isosorbide mononitrate versus sclerotherapy or shunt surgery for the prevention of variceal rebleeding: A randomized trial [abstr] Hepatology 20 1994 106A
192. R. McKee A study of octreotide in oesophageal varices Digestion 45 suppl 1 1990 60
193. M. McLaren S. Braye J. Fleming Changes in blood flow, portal pressure and shunting during the development of cirrhosis in response to beta-blockade Gut 28 1987 663
194. C. Merkel M. Bolognesi P. Angeli Prognostic indicators of survival in patients with cirrhosis and esophageal varices without previous bleeding Am J Gastroenterol 84 1989 717
195. C. Merkel G. Finnuci R. Zuin Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis J Hepatol 4 1987 174
196. C. Merkel A. Gatta R. Zuin Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension Digestion 32 1985 92
197. C. Merkel R. Marin E. Enzo Randomized trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale Lancet 348 1996 1677
198. P.P. Michielsen P.A. Pelckmans Haemodynamic changes in portal hypertension: New insights in the pathogenesis and clinical implications Acta Gastroenterol Belg 57 1994 194
199. S. Moncada R.M.J. Palmer E.A. Higgs Nitric oxide: Physiology, pathophysiology and pharmacology Pharmacol Rev 43 1991 109
200. R. Moreau D. Roulot A. Braillon Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: Evidence for an impaired cardiopulmonary baroreflex function Hepatology 10 1989 93
201. F. Moreno Merlo I.R. Wanless K. Shimamatsu The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis Hepatology 26 1997 554
202. M. Moreto M. Zaballa A. Bernal A randomized trial of tamponade or sclerotherapy as immediate treatment for bleeding esophageal varices Surg Gynecol Obstet 167 1988 331
203. R.M. Morillas R. Planas E. Cabre Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: Long-term hemodynamic and renal effects Hepatology 20 1994 1502
204. P. Mosca F.Y. Lee A.J. Kaumann Pharmacology of portal-systemic collaterals in portal hypertensive rats: Role of endothelin Am J Physiol 263 1992 G544
205. T. Mountokalakis N. Kallivretakis D. Mayopolou-Symvoulidou Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis Nephrol Dial Transplant 3 1988 604
206. G.S. Nace A.J. Wood Pharmacokinetics of long-acting propranolol: Implications for therapeutic use Clin Pharmacokinet 13 1987 51
207. N. Nagamine K. Ido N. Ueno The usefulness of ultrasonic microprobe imaging for endoscopic variceal ligation Am J Gastroenterol 91 1996 523
208. N. Nagamine N. Ueno T. Tomiyama A pilot study on modified endoscopic variceal ligation using endoscopic ultrasonography with color Doppler function (see comments) Am J Gastroenterol 93 1998 150
209. M. Navasa J. Chesta J. Bosch Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis: Effects on splanchnic and systemic hemodynamics and liver function Gastroenterology 96 1989 1110
210. P. Needleman E.M. Hohnson Vasodilators and the treatment of angina Gilman A.G. A.G. Gilman L.S. Goodman A. Gilman The Pharmacological Basis of Therapeutics ed 6 1980 Macmillan New York 819 833
211. F. Nevens R. Bustami I. Scheys Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic subjects Hepatology 27 1998 15
212. F. Nevens D. Sprengers J. Fevery The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis J Hepatol 20 1994 27
213. T. Nozue A. Kobayashi F. Uemasu Plasma endothelin-1 levels of children with cirrhosis J Pediatr Gastroenterol Nutr 21 1995 220
214. K.W. O'Connor G. Lehman H. Yune Comparison of three nonsurgical treatments for bleeding esophageal varices Gastroenterology 96 1989 899
215. K. Ohnishi T. Nakayama M. Saito Effects of propranolol on portal hemodynamics in patients with chronic liver disease Am J Gastroenterol 80 1985 132
216. L. Pagliaro A.K. Burroughs T.I.A. Sorensen Therapeutic controversies and randomized controlled trials: Prevention of bleeding and rebleeding in cirrhosis Gastroenterol Int 2 1989 71
217. L. Pagliaro G. D'Amico L. Pasta Portal hypertension in cirrhosis: Natural history J. Bosch R.J. Groszmann Portal Hypertension: Pathophysiology and Treatment 1994 Blackwell Scientific Publications Oxford 72 92
218. L. Pagliaro G. D'Amico T.I.A. Sorensen Prevention of first bleeding in cirrhosis: A meta-analysis of randomized trials of nonsurgical treatment Ann Intern Med 117 1992 59
219. J. Panes J.M. Bordas J.M. Pique Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy Hepatology 17 1993 213
220. J. Panes J. Teres J. Bosch Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices Dig Dis Sci 33 1988 454
221. K. Paquet Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices—a prospective controlled randomized trial Endoscopy 14 1982 4
222. K.J. Paquet H. Feussner Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: A prospective controlled randomized trial Hepatology 5 1985 580
223. G. Parelon P. Guiry J.P. Daures Prevention de la recidive hemoragique par rupture de varices oesphagiennes chez le cirrhotique: Etude controlee comparant le propranolol et la ligature de l'oesphage sur clip Presse Med 18 1989 1743
224. J.P. Pascal P. Cales Multicenter Study Group Propranolol in the prevention of first upper gastrointestinal hemorrhage in patients with cirrhosis of the liver and esophageal varices N Engl J Med 317 1988 856
225. R.M. Perez-Ayuso J.M. Pique J. Bosch Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis Lancet 337 1991 1431
226. P. Piai L. Cipolletta M. Claar Prophylactic sclerotherapy of high-risk esophageal varices: Results of a multicentric prospective controlled trial Hepatology 8 1988 1495
227. M. Pinzani P. Failli C. Ruocco Fat-storing cells as liver specific pericytes: Spatial dynamics of agonist-stimulated intracellular calcium transients J Clin Invest 90 1992 642
228. J.M. Pique M.P. Pizcuetta A.M. DeLacy Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats Hepatology 10 1989 953
229. R. Planas J.C. Quer J. Boix A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding Hepatology 20 1994 370
230. J. Polio R.J. Groszmann Hemodynamic factors involved in the development and rupture of esophageal varices: A pathophysiologic approach to treatment Semin Liver Dis 6 1986 318
231. G. Pomier-Layrargues J.P. Villenueva B. Willems Systemic and hepatic hemodynamics after variceal hemorrhage: Effects of propranolol and placebo Gastroenterology 93 1987 1218
232. T. Poynard P. Cales L. Pasta Beta-adrenergic antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices, an analysis of data and prognostic factors in 589 patients from four randomized clinical trials N Engl J Med 324 1991 1532
233. T. Poynard D. Lebrec P. Hillon Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleeding Hepatology 7 1987 447
234. D. Prandi B. Rueff J. Roche-Sicot Life-threatening hemorrhage of the digestive tract in cirrhotic patients Am J Surg 131 1976 204
235. M. Primignani B. Andreoni L. Carpinelli Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club Hepatology 21 1995 1322
236. A. Queneit P. Czernichow P. Ducrotte Etude controlee du propranolol dans la prevention des recidives hemorrhagiques chez des patients cirrhotiques Gastroenterol Clin Biol 11 1987 41
237. H. Qureshi S.J. Zuberi E. Alam Efficacy of oral propranolol and injection sclerotherapy in the long-term management of variceal bleeding Digestion 46 1990 193
238. W.G. Rector K.F. Hossack J.B. Ready Nitroglycerin for portal hypertension, a controlled comparison of the hemodynamic effects of graded doses J Hepatol 10 1990 375
239. S. Reichlin Somatostatin (part I) N Engl J Med 309 1983 1495
240. S. Reichlin Somatostatin N Engl J Med 309 1983 1556
241. J. Rigau J. Bosch J.M. Bordas Endoscopic measurement of variceal pressure in cirrhosis: Correlation with portal pressure and variceal hemorrhage Gastroenterology 96 1989 873
242. D.C. Rockey J. Chung Modulation of nitric oxide synthase III in sinusoidal endothelial cells: Implications for the pathogenesis of portal hypertension Hepatology 24 1996 190A
243. D.C. Rockey J.J. Chung Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension Gastroenterology 114 1998 344
244. J. Rodes The evolution of knowledge on the pathophysiology of portal hypertension R. DeFranchis Portal Hypertension II: Proceedings of the Second Baveno Consensus Workshop on Definitions, Methodology and Therapeutic Strategies 1996 Blackwell Science Oxford 18 29
245. F. Rodriguez-Perez R.J. Groszmann Pharmacologic treatment of portal hypertension Gastroenterol Clin North Am 21 1992 15
246. V. Rossi P. Cales J. Charneau Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: Prospective controlled trial of propranolol and sclerotherapy J Hepatol 12 1991 283
247. M. Rossle P. Deibert K. Haag TIPS versus sclerotherapy and β blockade: Preliminary results of a randomized study in patients with recurrent variceal hemorrhage [abstr] Hepatology 20 1994 A44
248. A. Saari E. Klvilaakso M. Inberg Comparison of somatostatin and vasopressin in bleeding esophageal varices Am J Gastroenterol 85 1990 804
249. C. Sabba G. Ferraioli P. Buanomico A randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients Gastroenterology 102 1992 1009
250. D. Sacerdoti C. Merkel A. Gatta Importance of 1 month effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis J Hepatol 12 1991 124
251. Z.A. Saeed The Saeed Six-Shooter: A prospective study of a new endoscopic multiple rubber-band ligator for the treatment of varices Endoscopy 28 1996 559
252. Z.A. Saeed G.V. Stiegmann F.C. Ramirez Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: A multicenter prospective randomized trial Hepatology 25 1997 71
253. M. Sakamoto T. Ueno M. Kin Ito cell contraction in response to endothelin-1 and substance P Hepatology 18 1993 978
254. J.M. Salmeron L. Ruiz Del Arbol A. Gines Isosorbide 5-mononitrate (ISMN) increases plasma renin activity (PRA) and aldosterone (ALD) and impairs renal function in cirrhosis and ascites J Hepatol 13 suppl 2 1991 S67
255. R.A. Sanowski J.P. Waring Endoscopic techniques and complications in variceal sclerotherapy J Clin Gastroenterol 9 1987 504
256. A.J. Sanyal A.M. Freedman V.A. Luketic Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy Gastroenterology 111 1996 138
257. S.K. Sarin Endoscopic sclerotherapy for esophago-gastric varices: A critical reappraisal Aust N Z J Med 19 1989 162
258. S.K. Sarin Diagnostic issues: Portal hypertensive gastropathy and gastric varices R. DeFranchis Portal Hypertension II: Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies 1996 Blackwell Science Oxford 30 55
259. S.K. Sarin A. Govil A.K. Jain Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence J Hepatol 26 1997 826
260. S.K. Sarin R.J. Groszmann P.G. Mosca Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension J Clin Invest 87 1991 1032
261. S.K. Sarin R.K. Guptan A.K. Jain A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding (see comments) Eur J Gastroenterol Hepatol 8 1996 337
262. S.K. Sarin A. Kumar Gastric varices: Profile, classification, and management Am J Gastroenterol 84 1989 1244
263. S.K. Sarin A. Kumar Sclerosants for variceal sclerotherapy: A critical appraisal Am J Gastroenterol 85 1990 641
264. S.K. Sarin D. Lahoti S.P. Saxena Prevalence, classification and natural history of gastric varices: Long-term follow up study in 568 patients with portal hypertension Hepatology 95 1992 434
265. S.K. Sarin G.S. Lamba M. Kumar Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding N Engl J Med 340 1999 988
266. S.K. Sarin R. Nanda G. Sachdev Intravariceal versus paravariceal sclerotherapy: A prospective, controlled, randomised trial Gut 28 1987 657
267. S.K. Sarin G. Sachdev R. Nanda Comparison of the two time schedules for endoscopic sclerotherapy: A prospective randomised controlled study Gut 27 1986 710
268. C. Scarpignato Clinical pharmacology of active variceal bleeding Dig Dis 10 suppl 1 1992 16
269. P.G. Schmid F.M. Sharabi G.B. Guo Vasopressin and oxytocin in the neural control of circulation Fed Proc 43 1984 97
270. B.M. Schuman J.W. Beckman F.J. Tedesco Complications of endoscopic injection sclerotherapy: A review Am J Gastroenterol 82 1987 823
271. C.C. Seiber R.J. Groszmann Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats Gastroenterology 103 1992 1043
272. D.G. Shand Propranolol N Engl J Med 293 1975 280
273. I.S. Sheen T.Y. Chen Y.F. Liaw Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis Liver 9 1989 1
274. R. Shields S.A. Jenkins J.N. Baxter A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices J Hepatol 16 1992 128
275. K. Shimamatsu I.R. Wanless Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver Hepatology 26 1997 343
276. C.C. Sieber G.A. Stalder [Pathophysiological and pharmacotherapeutic aspects of portal hypertension] Schweiz Med Wochenschr 123 1993 3
277. C. Silvain S. Carpienter D. Sautereau Terlipressin plus transdermal nitroglycerin vs octreotide in the control of acute bleeding from esophageal varices Hepatology 18 1993 61
278. J.L. Smith D.Y. Graham Variceal hemorrhage: A critical evaluation of survival analysis Gastroenterology 82 1982 968
279. C. Soderlund Endoscopic sclerotherapy of oesophageal varices: A clinical study Acta Chir Scand 524 suppl 1985 1
280. C. Soderlund T. Ihre Endoscopic sclerotherapy vs conservative management of bleeding oesophageal varices Acta Chir Scand 151 1985 449
281. G.E. Sonnenberg U. Keller A. Perruchud Effect of somatostatin on splanchnic hemodynamics Gastroenterology 80 1981 526
282. G.V. Stiegmann J.S. Goff Endoscopic esophageal varix ligation: Preliminary clinical experience Gastrointest Endosc 34 1988 113
283. G.V. Stiegmann J.S. Goff P.A. Michaletz-Onody Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices N Engl J Med 326 1992 1527
284. E. Strauss M.F.C. DeSa A. Albano A randomized controlled trial for the prevention of the first upper gastrointestinal bleeding due to portal hypertension in cirrhosis sclerotherapy or propranolol versus control groups Hepatology 8 1988 1395
285. J.J. Sung S.C. Chung C.W. Lai Octreotide infusion or emergency sclerotherapy for variceal haemorrhage (see comments) Lancet 342 1993 637
286. J.J. Sung S.C. Chung M.Y. Yung Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation Lancet 346 1995 1666
287. P. Svoboda I. Kantorova J. Ochmann A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices Surg Endosc 13 1999 580
288. J. Terblanche P.C. Bornmann D. Kahn Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding Lancet 2 1983 1328
289. J. Teres R. Baroni J.M. Bordas Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding J Hepatol 4 1987 159
290. J. Teres J. Bosch J.M. Bordas Propranolol versus sclerotherapy in preventing variceal rebleeding: A randomized controlled trial Gastroenterology 105 1993 1508
291. J. Teres A. Cecilia J.M. Bordas Esophageal tamponade for bleeding varices Gastroenterology 75 1978 566
292. The Copenhagen Esophageal Varices Sclerotherapy Project Sclerotherapy after first variceal hemorrhage in cirrhosis N Engl J Med 311 1984 1594
293. The Italian Multicenter Project for Propranolol in Prevention of Bleeding Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients: Final report of a multicenter randomized trial J Hepatol 9 1989 75
294. The PROVA Study Group Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicenter trial Hepatology 14 1991 1016
295. The Veterans Affairs Cooperative Variceal Sclerotherapy Group Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease: A randomized single-blind, multicenter clinical trial N Engl J Med 324 1991 1779
296. Y.T. Tsai C.S. Lay K.H. Lai Controlled trial of vasopressin plus nitroglycerin vs vasopressin alone in the treatment of bleeding esophageal varices Hepatology 6 1986 406
297. Y.T. Tsai F.Y. Lee H.C. Lin Hyposensitivity to vasopressin in patients with hepatitis-B related cirrhosis during acute hemorrhage from esophageal varices Hepatology 13 1991 407
298. Y.T. Tsai F.Y. Lee H.C. Lin Lack of effects of isosorbide-5 mononitrate on hepatic hemodynamics in HBsAg positive cirrhosis Hepatology 10 1989 283
299. G. Tyden G.E. Samnegaard L. Thulin Circulatory effects of somatostatin in anesthetized man Acta Chir Scand 145 1979 443
300. J.E. Valenzuela T. Schubert M.R. Fogel A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices Hepatology 10 1989 958
301. D. Valla C. Girod S.S. Lee Lack of vasopressin action on splanchnic hemodynamics during bleeding: A study in conscious portal hypertensive rats Hepatology 8 1988 10
302. D. Valla M.I. Jiron T. Poynard Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol J Hepatol 5 1987 144
303. Variceal Bleeding Study Group Glypressin vs somatostatin in the treatment of acute variceal bleeding in patients with cirrhosis a double-blind randomized controlled trial [abstr] Hepatology 19 1994 1361A
304. A. Viallet D. Marleau M. Huet Hemodynamic evaluation of patients with intrahepatic portal hypertension: Relationship between bleeding varices and the porto-hepatic gradient Gastroenterology 69 1975 1297
305. A. Vianna P.C. Hayes G. Moscoso Normal venous circulation of the gastroesophageal junction: A route to understanding varices Gastroenterology 93 1987 876
306. C. Vickers J. Rhodes P. Hillebrand Prospective controlled trial of propranolol and sclerotherapy for prevention of rebleeding from oesophageal varices Gut 28 1987 A1359
307. C. Villanueva J. Balanzo M.T. Novella Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding N Engl J Med 334 1996 1624
308. J.P. Villeneuve G. Pomier-Layrargues C. Infante-Rivard Propranolol for the prevention of recurrent variceal hemorrhage: A controlled study Hepatology 6 1986 1239
309. J.P. Vinel H. Lamouliatte P. Cales Propranolol reduced the rebleeding rate during endoscopic sclerotherapy before vacireal obliteration Gastroenterology 102 1992 1760
310. J. Vorobioff J.E. Bredfeldt R.J. Groszmann Hyperdynamic circulation in portal-hypertensive rat model: A primary factor for maintenance of chronic portal hypertension Am J Physiol 244 1983 G52
311. J. Vorobioff E. Picabea M. Gamen Isosorbide dinitrate in portal hypertensive patients J Hepatol 16 1992 387
312. J. Vorobioff E. Picabea R. Villavicencio Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients Hepatology 7 1987 648
313. I. Waked J. Korula Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experience Am J Med 102 1997 192
314. S.A. Waldman F. Murad Cyclic GMP synthesis and function Pharmacol Rev 39 1987 163
315. S. Walker H.P. Kreichgauer J.C. Bode Terlipressin vs somatostatin in bleeding esophageal varices: A controlled double-blind study Hepatology 15 1992 1023
316. S. Walker A. Steihl R. Raedsch Terlipressin in bleeding esophageal varices: A placebo-controlled double-blind study Hepatology 6 1986 112
317. T. Walle J.G. Webb E.E. Bagwell Stereoselective delivery and actions of beta receptor antagonists Biochem Pharmacol 37 1988 115
318. D. Westaby D.J. Bihari A.E.S. Gimson Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension Gut 25 1984 121
319. D. Westaby P.C. Hayes A.E.S. Gimson Controlled clinical trial of injection sclerotherapy for active variceal bleeding Hepatology 9 1989 274
320. D. Westaby B.R.D. Macdougall R. Williams Improved survival following injection sclerotherapy for esophageal varices: Final analysis of a controlled trial Hepatology 5 1985 827
321. D. Westaby W. Melia J. Hegarty Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration Hepatology 6 1986 673
322. D. Westaby W.M. Melia B.R.D. Macdougall Injection sclerotherapy for oesophageal varices: A prospective randomised trial of different treatment schedules Gut 25 1984 129
323. D. Westaby R.J. Polson A.E.S. Gimson A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding Hepatology 11 1990 353
324. L. Witzel E. Wolbergs H. Merki Prophylactic endoscopic sclerotherapy of esophageal varices: A prospective controlled trial Lancet 1 1985 773
325. M.F. Young R.A. Sanowski R. Rasche Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy (see comments) Gastrointest Endosc 39 1993 119
326. M. Zoli G. Marchesini A. Brunori Portal venous flow in response to acute β blocker and vasodilatory treatment in patients with liver cirrhosis Hepatology 6 1986 1248